22 September 2006
Increasing Kidneys Donor’s Pool by Machine Perfusion with the LifePort™ – Pilot Russian Study
O N Reznik, S F Bagnenko, I V Loginov, Y G MoisiukAnn Transplant 2006; 11(3): 46-48 :: ID: 497008
Abstract
The main problem of transplantology is deficit of organs. A renewal interest to using non heart beating (as too as marginal) donors is connected with the ischemic-reperfusion injury complications. Circumstances of explantation restrict the opportunities of using this kind of transplants because there are initial defects caused by ischemic damages. Using the machine perfusion enables to maximize the acceptance of marginal kidneys as the result of summarizing the processes of diagnoses, selection, treatment of kidney transplants during conservation.
Keywords: Kidney Transplantation, Marginal Kidneys Donors, Delayed Graft Function, Kidney Transplantation, Machine Perfusion
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






